Related Experiment Video

Updated: Jun 25, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Sequence diversity of hepatitis C virus: implications for immune control and therapy

Joerg Timm1, Michael Roggendorf

  • 1University of Essen, Institute of Virology, Hufelandst 55, Essen 45122, Germany. joerg.timm@uni-due.de

World Journal of Gastroenterology
|September 11, 2007
PubMed

Insights

Hepatitis C virus (HCV) diversity poses challenges for vaccines and treatments. Understanding viral evolution is key to developing effective therapies against this global health problem.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) infects 3% of the global population, causing chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
  • HCV's significant sequence diversity hinders vaccine development and therapeutic interventions.
  • The virus's error-prone polymerase leads to high mutation rates, enabling immune evasion and drug resistance.

Purpose of the Study:

  • To review the sequence diversity of HCV.
  • To explore the evolutionary driving forces of HCV.
  • To analyze the impact of HCV diversity on immune control and treatment response.

Main Methods:

  • Literature review focusing on HCV sequence diversity.
  • Analysis of viral evolution mechanisms.
  • Examination of immune response and treatment outcomes in relation to HCV genetic variability.

Main Results:

  • HCV exhibits enormous sequence diversity due to its high mutation rate.
  • Viral evolution facilitates adaptation to immune responses and selection of drug-resistant strains.
  • Targeting conserved viral regions is crucial for therapeutic and prophylactic strategies.

Conclusions:

  • Understanding HCV's evolutionary dynamics is fundamental for designing effective therapies.
  • Addressing viral diversity is essential for overcoming challenges in HCV treatment and prevention.
  • Future interventions must consider the limits and driving forces of HCV evolution.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...